| APPLICATIONS OF TECHNOLOGY:
ADVANTAGES:
|
| ABSTRACT: Bruce Cohen from Berkeley Lab has invented new photoactivatable, or "caged," quantum dots. These new probes are non-luminescent under typical microscopic illumination until activated with stronger pulses of UV light. This is the first time quantum dots have been dequenched using light. Current bioimaging technologies include photoactivatable organic flourophores and fluorescent proteins; however, the increased brightness and photostability offered by the Berkeley Lab nanocrystals is what sets them apart from conventional imaging agents. Using the Berkeley Lab caged nanocrystals, biological processes can be imaged in live cells while maximizing brightness and minimizing photobleaching. The photostability of these nanocrystals allows individual molecules to be tracked over extended periods. The Berkeley Lab caged quantum dots permit specific subcellular areas to be luminescent at a given time. For instance, illuminating the contents of the mitochondria would enable all molecules leaving the mitochondria to be tracked in real-time, offering enhanced data on fundamental biological processes and disease states. |
| STATUS:
|
To learn more about licensing a technology from LBNL see http://www.lbl.gov/Tech-Transfer/licensing/index.html. |
| FOR MORE INFORMATION: |
| REFERENCE NUMBER: IB-2521 |
| SEE THESE OTHER BERKELEY LAB TECHNOLOGIES IN THIS FIELD: |
